Cargando…
Urinary N-Acetyl-β-d-Glucosaminidase (NAG) Levels and Risk of Cardiovascular Events in Diabetic Patients
BACKGROUND: Cardiovascular diseases (CVDs) have a high incidence rate in population with diabetic patients. Studies on the association between urinary N-acetyl-β-d-glucosaminidase (NAG) levels, the biomarker of renal tubular damage, with cardiovascular (CV) events diabetic patients was still few. ME...
Autores principales: | Lou, Weiwei, Cheng, Qun, Liang, Yanqiu, Xia, Ding |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722575/ https://www.ncbi.nlm.nih.gov/pubmed/35002305 http://dx.doi.org/10.2147/IJGM.S337874 |
Ejemplares similares
-
Urinary Malondialdehyde (MDA) and N-Acetyl-β-D-Glucosaminidase (NAG) Associated with Exposure to Trichloroethylene (TCE) in Underground Water
por: Lin, Wen-Yu, et al.
Publicado: (2022) -
Urinary N-acetyl-beta-d-glucosaminidase levels in diabetic adults
por: Omozee, Eiya Bibiana, et al.
Publicado: (2019) -
Urinary N-Acetyl-Beta-D-Glucosaminidase levels predict immunoglobulin a nephropathy remission status
por: Liu, Xiao, et al.
Publicado: (2023) -
Association of Urinary N-Acetyl-β-D-Glucosaminidase with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Mellitus without Nephropathy
por: Choi, Min Sun, et al.
Publicado: (2021) -
Urinary biomarker N-acetyl-β-D-glucosaminidase can predict severity of renal damage in diabetic nephropathy
por: Sheira, Gehan, et al.
Publicado: (2015)